Professor Catherine Green

UK Clinical Vaccine Network Conference 2024
Wednesday 12th - Thursday 13th June 2024

Professor Catherine Green

Since 2018 Cath has been head of the University of Oxford’s Clinical BioManufacturing Facility (CBF). The CBF is licenced by the MHRA to manufacture sterile biological investigational medicine products (IMPs) according to Good Manufacturing Practice (GMP) for use in early phase clinical trials. Over the last 15 years the CBF has manufactured and released more than 30 vaccine batches, across a range of modalities (VLPs, recombinant proteins, Ad-vectored vaccines), aimed at preventing diseases including: Influenza, TB, Zika, Plague, MERS, Rabies, and COVID-19.

Top